Rosuvastatin vs Tofacitinib

## Rosuvastatin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Rosuvastatin** and **Tofacitinib**.

## Mechanism of Action

**Rosuvastatin**: Competitive inhibitor of HMG-CoA reductase.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Rosuvastatin — 19 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Rosuvastatin — C22H28FN3O6S; Tofacitinib — C16H20N6O.

**Molecular Weight**: Rosuvastatin — 481.5390 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Rosuvastatin — Small molecule; Tofacitinib — Small molecule.